Profile for World Intellectual Property Organization (WIPO) Patent: 2015164272
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2015164272
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,098,957 | Apr 20, 2035 | Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam |
| 10,213,510 | Apr 20, 2035 | Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam |
| 10,632,199 | Apr 20, 2035 | Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam |
| 10,898,575 | Apr 20, 2035 | Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam |
| 11,083,730 | Apr 20, 2035 | Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam |
| 11,083,797 | Apr 20, 2035 | Heron Theraps Inc | ZYNRELEF KIT | bupivacaine; meloxicam |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
